Safety and efficacy of gefapixant, a novel drug for the treatment of chronic cough: A systematic review and meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety and efficacy of gefapixant, a novel drug for the treatment of chronic cough: A systematic review and meta-analysis of randomized controlled trials

Published:2021 Issue:2 Volume:16 Page:127
ISSN:1817-1737
Container-title:Annals of Thoracic Medicine
language:en
Short-container-title:Ann Thorac Med

Author:

Abu-Zaid Ahmed,Aljaili AseelKhalid,Althaqib Amnah,Adem Fatima,Alhalal DoaaAli,Almubarak AmenaFaiq,Aldughaither SaudMusaab,Alghabban SarahAli,Alfaraj Ghaidaa,Masoud AhmedTaher,Alsuhaibani NujudAbdullah

Publisher

Medknow

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is there a biochemical basis for purinergic P2X3 and P2X4 receptor antagonists to be considered as anti-seizure medications?;Biochemical Pharmacology;2024-04

2. Molecular insights into P2X signalling cascades in acute kidney injury;Purinergic Signalling;2024-01-22

3. Safety and efficacy of P2X3 receptor antagonist for the treatment of refractory or unexplained chronic cough: A systematic review and meta-analysis of 11 randomized controlled trials;Pulmonary Pharmacology & Therapeutics;2023-12

4. Efficacy and safety of pharmacotherapy for refractory or unexplained chronic cough: a systematic review and network meta-analysis;eClinicalMedicine;2023-08

5. Efficacy and safety of gefapixant for chronic cough: a meta-analysis of randomised controlled trials;European Respiratory Review;2023-05-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP